Browsing Tag
PD-L1 cancers
1 post
Radiopharm Theranostics begins third-cohort enrolment in Phase 1 ¹⁷⁷Lu-RAD204 trial targeting PD-L1 tumours
Find out how Radiopharm Theranostics is advancing ¹⁷⁷Lu-RAD204 in PD-L1-positive tumours as it begins third-cohort enrolment in its Phase 1 trial.